Recent Publications
- Item Response Theory Quantifies the Relationship Between Improvements in Serum Phosphate and Patient-Reported Outcomes in Adults With X-Linked Hypophosphatemia.Mehta K, Gosselin NH, Insogna K, Barriere O, Quattrocchi E, Hruska MW, Marsteller D. Clin Pharmacol Ther. 2024 Nov; 2024 Aug 12. PMID: 39129452.
- Mitofusin 2 plays a critical role in maintaining the functional integrity of the neuromuscular-skeletal axis.Zhu M, Zeiss C, Hamrick MW, Weinstein RS, Sun BH, Brotto M, Liu X, Siu E, Huttner A, Tommasini S, Simpson C, Insogna K. Bone. 2024 Jul; 2024 Mar 27. PMID: 38552893.
- Effect of Burosumab on Muscle Function and Strength, and Rates of ATP Synthesis in Skeletal Muscle in Adults With XLH.Insogna KL, Sullivan R, Parziale S, Deng Y, Carrano D, Simpson C, Dufour S, Carpenter T, Petersen KF. J Clin Endocrinol Metab. 2024 Feb 20. PMID: 37930769.
- Circulating Levels of Leptin and Lipocalin-2 in Patients With X-Linked Hypophosphatemia.Simpson CA, Santoro AM, Carpenter TO, Deng Y, Parziale S, Insogna KL. J Endocr Soc. 2023 Oct 9; 2023 Oct 18. PMID: 37860221.
- Altered Expression of Several Molecular Mediators of Cerebrospinal Fluid Production in Hyp Mice.Kaplan J, Tommasini S, Yao GQ, Zhu M, Nishimura S, Ghazarian S, Louvi A, Insogna K. J Endocr Soc. 2023 Feb 9; 2023 Feb 6. PMID: 36819458.
- Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia.Weber TJ, Imel EA, Carpenter TO, Peacock M, Portale AA, Hetzer J, Merritt JL, Insogna K. J Clin Endocrinol Metab. 2022 Dec 17. PMID: 36072994.
- Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism.Minisola S, Arnold A, Belaya Z, Brandi ML, Clarke BL, Hannan FM, Hofbauer LC, Insogna KL, Lacroix A, Liberman U, Palermo A, Pepe J, Rizzoli R, Wermers R, Thakker RV. J Bone Miner Res. 2022 Nov; 2022 Oct 17. PMID: 36245271.
- Differing effects of oral conjugated equine estrogen and transdermal estradiol on vitamin D metabolism in postmenopausal women: a 4-year longitudinal study.Santoro AM, Simpson CA, Cong E, Haas A, Sullivan RR, Parziale S, Deng Y, Insogna KL. Menopause. 2022 Oct 1; 2022 Aug 20. PMID: 35969885.
- Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study.Brandi ML, Jan de Beur S, Briot K, Carpenter T, Cheong HI, Cohen-Solal M, Crowley RK, Eastell R, Imanishi Y, Imel EA, Ing SW, Insogna K, Ito N, Javaid K, Kamenicky P, Keen R, Kubota T, Lachmann RH, Perwad F, Pitukcheewanont P, Portale A, Ralston SH, Tanaka H, Weber TJ, Yoo HW, Sun W, Williams A, Nixon A, Takeuchi Y. Calcif Tissue Int. 2022 Oct; 2022 Aug 4. PMID: 35927518.
- Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data.Javaid MK, Ward L, Pinedo-Villanueva R, Rylands AJ, Williams A, Insogna K, Imel EA. J Clin Endocrinol Metab. 2022 Feb 17. PMID: 34636401.
- Corticosteroid use in chronic dermatologic disorders and osteoporosis.Lupsa BC, Insogna KL, Micheletti RG, Caplan A. Int J Womens Dermatol. 2021 Dec; 2021 Aug 15. PMID: 35024411.
- Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing.Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, Martin JS, Carpenter TO. J Bone Miner Res. 2021 Dec; 2021 May 24. PMID: 34030212.
- Update on Osteoporosis Screening and Management.Anam AK, Insogna K. Med Clin North Am. 2021 Nov; 2021 Sep 8. PMID: 34688418.
- Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension.Briot K, Portale AA, Brandi ML, Carpenter TO, Cheong HI, Cohen-Solal M, Crowley RK, Eastell R, Imanishi Y, Ing S, Insogna K, Ito N, Jan de Beur S, Javaid MK, Kamenicky P, Keen R, Kubota T, Lachmann RH, Perwad F, Pitukcheewanont P, Ralston SH, Takeuchi Y, Tanaka H, Weber TJ, Yoo HW, Nixon A, Nixon M, Sun W, Williams A, Imel EA. RMD Open. 2021 Sep. PMID: 34548383.
- An Unanticipated Role for Sphingosine Kinase-2 in Bone and in the Anabolic Effect of Parathyroid Hormone.Walker JM, Yao GQ, Siu E, Zhu M, Sun BH, Simpson C, Insogna KL. Endocrinology. 2021 May 1. PMID: 33640975.
- Burosumab for the Treatment of Tumor-Induced Osteomalacia.Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO. J Bone Miner Res. 2021 Apr; 2021 Jan 12. PMID: 33338281.
- Selective deletion of the receptor for CSF1, c-fms, in osteoclasts results in a high bone mass phenotype, smaller osteoclasts in vivo and an impaired response to an anabolic PTH regimen.Zhu M, Sun BH, Nevius E, Kaplan J, Pereira J, Insogna K. PLoS One. 2021; 2021 Feb 19. PMID: 33607650.
- New Therapies for Hypophosphatemia-Related to FGF23 Excess.Athonvarangkul D, Insogna KL. Calcif Tissue Int. 2021 Jan; 2020 Jun 5. PMID: 32504139.
- Identification of a 22 bp DNA cis Element that Plays a Critical Role in Colony Stimulating Factor 1-Dependent Transcriptional Activation of the SPHK1 Gene.Yao GQ, Zhu M, Walker J, Insogna K. Calcif Tissue Int. 2020 Jul; 2020 Apr 3. PMID: 32246175.
- Corrigendum to "Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutation" [Bone Rep. 9 (2018) 154-158].Timme K, Rangel ES, Yuan Q, Wu D, Carpenter TO, Insogna K. Bone Rep. 2020 Jun; 2020 Mar 14. PMID: 32195293.
- Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial.Insogna KL, Rauch F, Kamenický P, Ito N, Kubota T, Nakamura A, Zhang L, Mealiffe M, San Martin J, Portale AA. J Bone Miner Res. 2019 Dec; 2019 Oct 1. PMID: 31369697.
- Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.Portale AA, Carpenter TO, Brandi ML, Briot K, Cheong HI, Cohen-Solal M, Crowley R, Jan De Beur S, Eastell R, Imanishi Y, Imel EA, Ing S, Ito N, Javaid M, Kamenicky P, Keen R, Kubota T, Lachmann R, Perwad F, Pitukcheewanont P, Ralston SH, Takeuchi Y, Tanaka H, Weber TJ, Yoo HW, Zhang L, Theodore-Oklota C, Mealiffe M, San Martin J, Insogna K. Calcif Tissue Int. 2019 Sep; 2019 Jun 4. PMID: 31165191.
- Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia.Zhang C, Zhao Z, Sun Y, Xu L, JiaJue R, Cui L, Pang Q, Jiang Y, Li M, Wang O, He X, He S, Nie M, Xing X, Meng X, Zhou X, Yan L, Kaplan JM, Insogna KL, Xia W. Bone. 2019 Apr; 2019 Jan 23. PMID: 30682568.
- Primary Hyperparathyroidism.Insogna KL. N Engl J Med. 2018 Dec 20. PMID: 30575486.
- Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutation.Ang K, Sanchez Rangel E, Yuan Q, Wu D, Carpenter TO, Insogna K. Bone Rep. 2018 Dec; 2018 Sep 19. PMID: 30364642.
- The contribution of cross-talk between the cell-surface proteins CD36 and CD47-TSP-1 in osteoclast formation and function.Koduru SV, Sun BH, Walker JM, Zhu M, Simpson C, Dhodapkar M, Insogna KL. J Biol Chem. 2018 Sep 28; 2018 Aug 6. PMID: 30082316.
- Primary Hyperparathyroidism.Insogna KL. N Engl J Med. 2018 Sep 13. PMID: 30207907.
- A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.Insogna KL, Briot K, Imel EA, Kamenický P, Ruppe MD, Portale AA, Weber T, Pitukcheewanont P, Cheong HI, Jan de Beur S, Imanishi Y, Ito N, Lachmann RH, Tanaka H, Perwad F, Zhang L, Chen CY, Theodore-Oklota C, Mealiffe M, San Martin J, Carpenter TO. J Bone Miner Res. 2018 Aug; 2018 Jun 26. PMID: 29947083.
- Three-Month Randomized Clinical Trial of Nasal Calcitonin in Adults with X-linked Hypophosphatemia.Sullivan R, Abraham A, Simpson C, Olear E, Carpenter T, Deng Y, Chen C, Insogna KL. Calcif Tissue Int. 2018 Jun; 2018 Jan 30. PMID: 29383408.
- Animal versus plant protein and adult bone health: A systematic review and meta-analysis from the National Osteoporosis Foundation.Shams-White MM, Chung M, Fu Z, Insogna KL, Karlsen MC, LeBoff MS, Shapses SA, Sackey J, Shi J, Wallace TC, Weaver CM. PLoS One. 2018; 2018 Feb 23. PMID: 29474360.
- Associations among circulating colony-stimulating factor-1, estrogen, and bone mineral density in postmenopausal women: results from a randomized placebo-controlled trial.Haas AV, Cong E, Simpson CA, Sukumar N, Deng Y, Insogna KL. Menopause. 2018 Feb. PMID: 28816930.
- Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps.Hsieh E, Wang Q, Zhang R, Niu X, Xia W, Fraenkel L, Insogna KL, Li J, Smith JS, Zhou C, Qiao YL, Zhang P. BMC Cancer. 2018 Jan 30; 2018 Jan 30. PMID: 29378534.
- Selective deletion of the soluble Colony-Stimulating Factor 1 isoform in vivo prevents estrogen-deficiency bone loss in mice.Yao GQ, Troiano N, Simpson CA, Insogna KL. Bone Res. 2017; 2017 Nov 14. PMID: 29152381.
- Breast cancer-associated gene 3 interacts with Rac1 and augments NF-κB signaling in vitro, but has no effect on RANKL-induced bone resorption in vivo.Yao C, Yu KP, Philbrick W, Sun BH, Simpson C, Zhang C, Insogna K. Int J Mol Med. 2017 Oct; 2017 Aug 4. PMID: 28791343.
- The Yale Fitness Intervention Trial in female cancer survivors: Cardiovascular and physiological outcomes.Knobf MT, Jeon S, Smith B, Harris L, Thompson S, Stacy MR, Insogna K, Sinusas AJ. Heart Lung. 2017 Sep-Oct; 2017 Aug 10. PMID: 28803675.
- Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group.Wu CC, Econs MJ, DiMeglio LA, Insogna KL, Levine MA, Orchard PJ, Miller WP, Petryk A, Rush ET, Shoback DM, Ward LM, Polgreen LE. J Clin Endocrinol Metab. 2017 Sep 1. PMID: 28655174.
- Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation.Shams-White MM, Chung M, Du M, Fu Z, Insogna KL, Karlsen MC, LeBoff MS, Shapses SA, Sackey J, Wallace TC, Weaver CM. Am J Clin Nutr. 2017 Jun; 2017 Apr 12. PMID: 28404575.
- The Effect of Dietary Glycemic Properties on Markers of Inflammation, Insulin Resistance, and Body Composition in Postmenopausal American Women: An Ancillary Study from a Multicenter Protein Supplementation Trial.Stojkovic V, Simpson CA, Sullivan RR, Cusano AM, Kerstetter JE, Kenny AM, Insogna KL, Bihuniak JD. Nutrients. 2017 May 11; 2017 May 11. PMID: 28492492.
- Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial.Viscoli CM, Inzucchi SE, Young LH, Insogna KL, Conwit R, Furie KL, Gorman M, Kelly MA, Lovejoy AM, Kernan WN. J Clin Endocrinol Metab. 2017 Mar 1. PMID: 27935736.
- Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia.Ruppe MD, Zhang X, Imel EA, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey JS, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO. Bone Rep. 2016 Dec; 2016 May 13. PMID: 28326356.
- Hypophosphatemia promotes lower rates of muscle ATP synthesis.Pesta DH, Tsirigotis DN, Befroy DE, Caballero D, Jurczak MJ, Rahimi Y, Cline GW, Dufour S, Birkenfeld AL, Rothman DL, Carpenter TO, Insogna K, Petersen KF, Bergwitz C, Shulman GI. FASEB J. 2016 Oct; 2016 Jun 23. PMID: 27338702.
- The liver throws the skeleton a bone (resorption factor).Chung C, Insogna KL. Hepatology. 2016 Sep; 2016 Jul 25. PMID: 27312397.
- Longitudinal increase in vitamin D binding protein levels after initiation of tenofovir/lamivudine/efavirenz among individuals with HIV.Hsieh E, Fraenkel L, Han Y, Xia W, Insogna KL, Yin MT, Zhu T, Cheng X, Li T. AIDS. 2016 Jul 31. PMID: 27124896.
- Deletion of Rac in Mature Osteoclasts Causes Osteopetrosis, an Age-Dependent Change in Osteoclast Number, and a Reduced Number of Osteoblasts In Vivo.Zhu M, Sun BH, Saar K, Simpson C, Troiano N, Dallas SL, Tiede-Lewis LM, Nevius E, Pereira JP, Weinstein RS, Tommasini SM, Insogna KL. J Bone Miner Res. 2016 Apr; 2015 Nov 18. PMID: 26496249.
- Effect of a randomized controlled exercise trial on bone outcomes: influence of adjuvant endocrine therapy.Knobf MT, Jeon S, Smith B, Harris L, Kerstetter J, Thompson AS, Insogna K. Breast Cancer Res Treat. 2016 Feb; 2016 Feb 5. PMID: 26850265.
- Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.Zhang X, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey J, Glorieux FH, Portale AA, Insogna K, Carpenter TO, Peacock M. J Clin Pharmacol. 2016 Feb; 2015 Aug 11. PMID: 26073451.
- AgRP Neurons Regulate Bone Mass.Kim JG, Sun BH, Dietrich MO, Koch M, Yao GQ, Diano S, Insogna K, Horvath TL. Cell Rep. 2015 Oct 6; 2015 Sep 24. PMID: 26411686.
- Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease.Connor J, Olear EA, Insogna KL, Katz L, Baker S, Kaur R, Simpson CA, Sterpka J, Dubrow R, Zhang JH, Carpenter TO. J Clin Endocrinol Metab. 2015 Oct; 2015 Jul 15. PMID: 26176801.
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.Ho PC, Bihuniak JD, Macintyre AN, Staron M, Liu X, Amezquita R, Tsui YC, Cui G, Micevic G, Perales JC, Kleinstein SH, Abel ED, Insogna KL, Feske S, Locasale JW, Bosenberg MW, Rathmell JC, Kaech SM. Cell. 2015 Sep 10; 2015 Aug 27. PMID: 26321681.
- Bone Health and Osteoporosis.Lupsa BC, Insogna K. Endocrinol Metab Clin North Am. 2015 Sep. PMID: 26316240.
- The effects of dietary protein and amino acids on skeletal metabolism.Bihuniak JD, Insogna KL. Mol Cell Endocrinol. 2015 Jul 15; 2015 Apr 2. PMID: 25843057.
- Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23.Imel EA, Zhang X, Ruppe MD, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey JS, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO. J Clin Endocrinol Metab. 2015 Jul; 2015 Apr 28. PMID: 25919461.
- The Effect of a Whey Protein Supplement on Bone Mass in Older Caucasian Adults.Kerstetter JE, Bihuniak JD, Brindisi J, Sullivan RR, Mangano KM, Larocque S, Kotler BM, Simpson CA, Cusano AM, Gaffney-Stomberg E, Kleppinger A, Reynolds J, Dziura J, Kenny AM, Insogna KL. J Clin Endocrinol Metab. 2015 Jun; 2015 Apr 6. PMID: 25844619.
- Effect of 25(OH) vitamin D reference method procedure (RMP) alignment on clinical measurements obtained with the IDS-iSYS chemiluminescent-based automated analyzer.Simpson CA, Cusano AM, Bihuniak J, Walker J, Insogna KL. J Steroid Biochem Mol Biol. 2015 Apr; 2014 Sep 18. PMID: 25239596.
- Dietary Protein and Vitamin D Intake and Risk of Falls: A Secondary Analysis of Postmenopausal Women from the Study of Osteoporotic Fractures.Larocque SC, Kerstetter JE, Cauley JA, Insogna KL, Ensrud K, Lui LY, Allore HG. J Nutr Gerontol Geriatr. 2015. PMID: 26267443.
- Duodenal absorption and tissue utilization of dietary heme and nonheme iron differ in rats.Cao C, Thomas CE, Insogna KL, O'Brien KO. J Nutr. 2014 Nov; 2014 Sep 10. PMID: 25332470.
- Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis.Dasgupta D, Wee MJ, Reyes M, Li Y, Simm PJ, Sharma A, Schlingmann KP, Janner M, Biggin A, Lazier J, Gessner M, Chrysis D, Tuchman S, Baluarte HJ, Levine MA, Tiosano D, Insogna K, Hanley DA, Carpenter TO, Ichikawa S, Hoppe B, Konrad M, Sävendahl L, Munns CF, Lee H, Jüppner H, Bergwitz C. J Am Soc Nephrol. 2014 Oct; 2014 Apr 3. PMID: 24700880.
- Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled study.Carpenter TO, Olear EA, Zhang JH, Ellis BK, Simpson CA, Cheng D, Gundberg CM, Insogna KL. J Clin Endocrinol Metab. 2014 Sep; 2014 Jul 16. PMID: 25029424.
- Denosumab for treatment of hypercalcemia of malignancy.Hu MI, Glezerman IG, Leboulleux S, Insogna K, Gucalp R, Misiorowski W, Yu B, Zorsky P, Tosi D, Bessudo A, Jaccard A, Tonini G, Ying W, Braun A, Jain RK. J Clin Endocrinol Metab. 2014 Sep; 2014 Jun 10. PMID: 24915117.
- Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Wooddell MM, Kawakami T, Ito T, Zhang X, Humphrey J, Insogna KL, Peacock M. J Clin Invest. 2014 Apr; 2014 Feb 24. PMID: 24569459.
- Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5.Lee GS, Simpson C, Sun BH, Yao C, Foer D, Sullivan B, Matthes S, Alenina N, Belsky J, Bader M, Insogna KL. J Bone Miner Res. 2014 Apr. PMID: 24038240.
- The transcription factor T-box 3 regulates colony-stimulating factor 1-dependent Jun dimerization protein 2 expression and plays an important role in osteoclastogenesis.Yao C, Yao GQ, Sun BH, Zhang C, Tommasini SM, Insogna K. J Biol Chem. 2014 Mar 7; 2014 Jan 6. PMID: 24394418.
- Supplementing a low-protein diet with dibasic amino acids increases urinary calcium excretion in young women.Bihuniak JD, Sullivan RR, Simpson CA, Caseria DM, Huedo-Medina TB, O'Brien KO, Kerstetter JE, Insogna KL. J Nutr. 2014 Mar; 2014 Jan 15. PMID: 24431325.
- Dietary acid load is associated with lower bone mineral density in men with low intake of dietary calcium.Mangano KM, Walsh SJ, Kenny AM, Insogna KL, Kerstetter JE. J Bone Miner Res. 2014 Feb. PMID: 23873776.
- Osteoporosis knowledge, self-efficacy, and health beliefs among Chinese individuals with HIV.Hsieh E, Fraenkel L, Bradley EH, Xia W, Insogna KL, Cui Q, Li K, Li T. Arch Osteoporos. 2014; 2014 Dec 9. PMID: 25487753.
- Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.Hu MI, Glezerman I, Leboulleux S, Insogna K, Gucalp R, Misiorowski W, Yu B, Ying W, Jain RK. J Natl Cancer Inst. 2013 Sep 18; 2013 Aug 29. PMID: 23990665.
- Increasing dietary protein acutely augments intestinal iron transporter expression and significantly increases iron absorption in rats.Thomas CE, Gaffney-Stomberg E, Sun BH, O'Brien KO, Kerstetter JE, Insogna KL. FASEB J. 2013 Jun; 2013 Feb 27. PMID: 23447582.
- Dietary protein-induced increases in urinary calcium are accompanied by similar increases in urinary nitrogen and urinary urea: a controlled clinical trial.Bihuniak JD, Simpson CA, Sullivan RR, Caseria DM, Kerstetter JE, Insogna KL. J Acad Nutr Diet. 2013 Mar. PMID: 23438496.
- Claudins, dietary milk proteins, and intestinal barrier regulation.Kotler BM, Kerstetter JE, Insogna KL. Nutr Rev. 2013 Jan. PMID: 23282252.
- LIM kinase 1 deficient mice have reduced bone mass.Kawano T, Zhu M, Troiano N, Horowitz M, Bian J, Gundberg C, Kolodziejczak K, Insogna K. Bone. 2013 Jan; 2012 Sep 24. PMID: 23017662.
- Selective deletion of the membrane-bound colony stimulating factor 1 isoform leads to high bone mass but does not protect against estrogen-deficiency bone loss.Yao GQ, Wu JJ, Troiano N, Zhu ML, Xiao XY, Insogna K. J Bone Miner Metab. 2012 Jul; 2011 Nov 23. PMID: 22105655.
- Phosphorus-31 MRI of hard and soft solids using quadratic echo line-narrowing.Frey MA, Michaud M, VanHouten JN, Insogna KL, Madri JA, Barrett SE. Proc Natl Acad Sci U S A. 2012 Apr 3; 2012 Mar 19. PMID: 22431609.
- A clinician's guide to X-linked hypophosphatemia.Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. J Bone Miner Res. 2011 Jul; 2011 May 2. PMID: 21538511.
- Calcium intake in the United States from dietary and supplemental sources across adult age groups: new estimates from the National Health and Nutrition Examination Survey 2003-2006.Mangano KM, Walsh SJ, Insogna KL, Kenny AM, Kerstetter JE. J Am Diet Assoc. 2011 May. PMID: 21515114.
- Calcitonin administration in X-linked hypophosphatemia.Liu ES, Carpenter TO, Gundberg CM, Simpson CA, Insogna KL. N Engl J Med. 2011 Apr 28. PMID: 21524226.
- Control of bone formation by the serpentine receptor Frizzled-9.Albers J, Schulze J, Beil FT, Gebauer M, Baranowsky A, Keller J, Marshall RP, Wintges K, Friedrich FW, Priemel M, Schilling AF, Rueger JM, Cornils K, Fehse B, Streichert T, Sauter G, Jakob F, Insogna KL, Pober B, Knobeloch KP, Francke U, Amling M, Schinke T. J Cell Biol. 2011 Mar 21; 2011 Mar 14. PMID: 21402791.
- Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice.Yao GQ, Wu JJ, Troiano N, Insogna K. J Bone Miner Metab. 2011 Mar; 2010 Jul 3. PMID: 20602130.
- Dietary protein and skeletal health: a review of recent human research.Kerstetter JE, Kenny AM, Insogna KL. Curr Opin Lipidol. 2011 Feb. PMID: 21102327.
- Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity.Itokowa T, Zhu ML, Troiano N, Bian J, Kawano T, Insogna K. Calcif Tissue Int. 2011 Jan; 2010 Nov 26. PMID: 21110188.
- Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status.Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM. J Clin Endocrinol Metab. 2010 Nov; 2010 Aug 4. PMID: 20685863.
- Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial.Wright MJ, Sullivan RR, Gaffney-Stomberg E, Caseria DM, O'Brien KO, Proctor DD, Simpson CA, Kerstetter JE, Insogna KL. J Bone Miner Res. 2010 Oct. PMID: 20499372.
- Optimizing bone health in older adults: the importance of dietary protein.Surdykowski AK, Kenny AM, Insogna KL, Kerstetter JE. Aging health. 2010 Jun 1. PMID: 20657805.
- The effect of dietary protein on intestinal calcium absorption in rats.Gaffney-Stomberg E, Sun BH, Cucchi CE, Simpson CA, Gundberg C, Kerstetter JE, Insogna KL. Endocrinology. 2010 Mar; 2010 Feb 10. PMID: 20147526.
- Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.Kukreja A, Radfar S, Sun BH, Insogna K, Dhodapkar MV. Blood. 2009 Oct 15; 2009 Aug 6. PMID: 19661269.
- Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice.Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM. Calcif Tissue Int. 2009 Sep; 2009 Jul 17. PMID: 19609735.
- Increasing dietary protein requirements in elderly people for optimal muscle and bone health.Gaffney-Stomberg E, Insogna KL, Rodriguez NR, Kerstetter JE. J Am Geriatr Soc. 2009 Jun; 2009 Apr 30. PMID: 19460090.
- Targeted overexpression of the two colony-stimulating factor-1 isoforms in osteoblasts differentially affects bone loss in ovariectomized mice.Yao GQ, Wu JJ, Ovadia S, Troiano N, Sun BH, Insogna K. Am J Physiol Endocrinol Metab. 2009 Apr; 2009 Jan 13. PMID: 19141689.
- The effect of proton pump-inhibiting drugs on mineral metabolism.Insogna KL. Am J Gastroenterol. 2009 Mar. PMID: 19262542.
- Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone.Williams BO, Insogna KL. J Bone Miner Res. 2009 Feb. PMID: 19072724.
- Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G. Cell. 2008 Nov 28. PMID: 19041748.
- Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial.Miki RA, Oetgen ME, Kirk J, Insogna KL, Lindskog DM. J Bone Joint Surg Am. 2008 Nov. PMID: 18978403.
- A patient with hypophosphatemia, a femoral fracture, and recurrent kidney stones: report of a novel mutation in SLC34A3.Page K, Bergwitz C, Jaureguiberry G, Harinarayan CV, Insogna K. Endocr Pract. 2008 Oct. PMID: 18996815.
- The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice.Kawano T, Troiano N, Adams DJ, Wu JJ, Sun BH, Insogna K. Endocrinology. 2008 Aug; 2008 May 8. PMID: 18467443.
- An aerobic weight-loaded pilot exercise intervention for breast cancer survivors: bone remodeling and body composition outcomes.Knobf MT, Insogna K, DiPietro L, Fennie C, Thompson AS. Biol Res Nurs. 2008 Jul. PMID: 18705153.
- Can serum pentosidine levels predict risk of vertebral fracture in patients with type 2 diabetes mellitus?Insogna K. Nat Clin Pract Endocrinol Metab. 2008 Jul; 2008 May 6. PMID: 18461065.
- Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling.Garimella R, Tague SE, Zhang J, Belibi F, Nahar N, Sun BH, Insogna K, Wang J, Anderson HC. J Histochem Cytochem. 2008 Jun; 2008 Mar 3. PMID: 18319273.
- Impact of glucose-dependent insulinotropic peptide on age-induced bone loss.Ding KH, Shi XM, Zhong Q, Kang B, Xie D, Bollag WB, Bollag RJ, Hill W, Washington W, Mi QS, Insogna K, Chutkan N, Hamrick M, Isales CM. J Bone Miner Res. 2008 Apr. PMID: 18072880.
- The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.Nakchbandi IA, Lang R, Kinder B, Insogna KL. J Clin Endocrinol Metab. 2008 Mar; 2007 Dec 11. PMID: 18073309.
- Proton pump-inhibiting drugs, calcium homeostasis, and bone health.Wright MJ, Proctor DD, Insogna KL, Kerstetter JE. Nutr Rev. 2008 Feb. PMID: 18254877.
- Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass.Xie D, Zhong Q, Ding KH, Cheng H, Williams S, Correa D, Bollag WB, Bollag RJ, Insogna K, Troiano N, Coady C, Hamrick M, Isales CM. Bone. 2007 May; 2007 Jan 20. PMID: 17321229.